SPRY2 and neoplasm: Spry2 is frequently found to function as tumor suppressor in cancers of e.g., lung [21,22], breast [23], and liver [24]), but in other tumor entities it exerts tumor promoting tasks (e.g., in colon [25] and brain [26,27] cancers).